Actionable news
All posts from Actionable news
Actionable news in CEMP: Cempra, Inc.,

Leerink Swann Initiates Market Perform on Cempra Inc; Sees 22% Upside for the Stock

In a research report issued Tuesday, Leerink Swann analyst Paul Matteis initiated coverage on shares of Cempra Inc (NASDAQ:CEMP), with a Market Perform rating and price target of $31, which represents a potential upside of 22% from where the stock is currently trading.

Matteis commented: “While we are confident in the potential of lead product Solithromycin (Community Acquired Bacterial Pneumonia [CABP]), we believe CEMP...